Publicação
Optimizing the Use of Renin‑Angiotensin System Inhibition in Advanced Chronic Kidney Disease
| Resumo: | Abstract Chronic kidney disease (CKD) affects millions of people worldwide and is a major public health problem. Renin‑angiotensin system inhibitors are the backbone drugs for preventing CKD progression but have potential side effects, such as hyperkalemia or acute decrease in glomerular filtration rate, which can prevent physicians from starting the drugs, or even lead physicians to stop the drug when already in use in advanced CKD patients. In this review, the principal studies performed on this topic are summarized. |
|---|---|
| Autores principais: | Ferreira,Ana Carina |
| Assunto: | Angiotensin Receptor Antagonists/therapeutic use Angiotensin‑Converting Enzyme Inhibitors/therapeutic use Kidney Failure, Chronic/drug therapy Renal Insufficiency, Chronic/drug therapy |
| Ano: | 2024 |
| País: | Portugal |
| Tipo de documento: | artigo |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Fundação para a Ciência e Tecnologia |
| Idioma: | inglês |
| Origem: | SciELO Portugal |
| Resumo: | Abstract Chronic kidney disease (CKD) affects millions of people worldwide and is a major public health problem. Renin‑angiotensin system inhibitors are the backbone drugs for preventing CKD progression but have potential side effects, such as hyperkalemia or acute decrease in glomerular filtration rate, which can prevent physicians from starting the drugs, or even lead physicians to stop the drug when already in use in advanced CKD patients. In this review, the principal studies performed on this topic are summarized. |
|---|
Atividades financiadas
Não foram encontrados projetos financiados.